In more details, the inhibition of T cells expressing high levels of CD25 may be efficacious in Crohn’s disease, but harmful in type 1 diabetes and juvenile rheumatoid arthritis for which a stimulation of the same cells is likely to be effective. This evidence concerns the gene IL2RA and type 1 diabetes mellitus.